Molecular Clamp Stabilized Spike Vaccine for Rapid Response

Circulating effector γδ T cell populations are associated with acute coronavirus disease 19 in unvaccinated individuals

A von Borstel, THO Nguyen, LC Rowntree, TM Ashhurst, LF Allen, LJ Howson, NE Holmes, OC Smibert, JA Trubiano, CL Gordon, AC Cheng, SJ Kent, J Rossjohn, K Kedzierska, MS Davey

2023-04-01

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes severe coronavirus disease 2019 (COVID-19) in a smal..

Robust SARS-CoV- 2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments

E Zhang, THO Nguyen, LF Allen, L Kedzierski, LC Rowntree, SY Chang, W Zhang, JR Habel, IJ Foo, T Menon, J Mitchell, RW Leong, K Bond, DA Williamson, K Kedzierska, B Christensen

2023-03-06

Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity

W Zhang, LC Rowntree, R Muttucumaru, T Damelang, M Aban, AC Hurt, M Auladell, R Esterbauer, B Wines, M Hogarth, SJ Turner, AK Wheatley, SJ Kent, S Patil, S Avery, O Morrissey, AW Chung, M Koutsakos, THO Nguyen, AC Cheng

2023-01-01

Objectives: Influenza causes significant morbidity and mortality, especially in high-risk populations. Although current vaccinatio..

SARS-CoV-2-specific CD8 T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph

LC Rowntree, J Petersen, JA Juno, P Chaurasia, K Wragg, M Koutsakos, L Hensen, AK Wheatley, SJ Kent, J Rossjohn, K Kedzierska, THO Nguyen

2021-10-01

In-depth understanding of human T-cell-mediated immunity in coronavirus disease 2019 (COVID-19) is needed if we are to optimize va..